Advances in pathogenesis and therapy of hemolytic uremic syndrome caused by Shiga toxin-2 (Q26863602)

María Marta Amaral

series ordinal

2

1 reference

Marina S. Palermo

series ordinal

3

1 reference

language of work or name

1 reference

October 2013

1 reference

1 reference

65

1 reference

issue

10

1 reference

page(s)

827-35

1 reference

A comparison of Shiga-toxin 2 bacteriophage from classical enterohemorrhagic Escherichia coli serotypes and the German E. coli O104:H4 outbreak strain

cites work

1 reference

Lessons Learned From Outbreaks of Shiga Toxin Producing Escherichia coli

21 January 2018

1 reference

The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli

21 January 2018

1 reference

The enemy within us: lessons from the 2011 European Escherichia coli O104:H4 outbreak

21 January 2018

1 reference

Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study

21 January 2018

1 reference

Shiga toxin 1 triggers a ribotoxic stress response leading to p38 and JNK activation and induction of apoptosis in intestinal epithelial cells

21 January 2018

1 reference

Localization of the binding site for the oligosaccharide moiety of Gb3 on verotoxin 1 using NMR residual dipolar coupling measurements

21 January 2018

1 reference

Hemolytic uremic syndrome: pathogenesis and update of interventions

21 January 2018

1 reference

Functional and genetic analysis of regulatory regions of coliphage H-19B: location of shiga-like toxin and lysis genes suggest a role for phage functions in toxin release.

21 January 2018

1 reference

Prophage induction is enhanced and required for renal disease and lethality in an EHEC mouse model

21 January 2018

1 reference

Shiga toxin-encoding bacteriophages--genomes in motion

21 January 2018

1 reference

Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice.

21 January 2018

1 reference

Role for a phage promoter in Shiga toxin 2 expression from a pathogenic Escherichia coli strain.

21 January 2018

1 reference

Shiga-toxin-converting bacteriophages.

21 January 2018

1 reference

Nonpathogenic Escherichia coli can contribute to the production of Shiga toxin

21 January 2018

1 reference

In vivo transduction of an Stx-encoding phage in ruminants.

21 January 2018

1 reference

In vivo gene delivery and expression by bacteriophage lambda vectors

21 January 2018

1 reference

Exocytotic secretion of toxins from macrophages infected with Escherichia coli O157.

21 January 2018

1 reference

Functional capacity of Shiga-toxin promoter sequences in eukaryotic cells

21 January 2018

1 reference

Host and pathogen determinants of verocytotoxin-producing Escherichia coli-associated hemolytic uremic syndrome

21 January 2018

1 reference

Shiga toxin 2 overexpression in Escherichia coli O157:H7 strains associated with severe human disease

21 January 2018

1 reference

Human microbiota-secreted factors inhibit shiga toxin synthesis by enterohemorrhagic Escherichia coli O157:H7.

21 January 2018

1 reference

Shiga toxin-producing Escherichia coli O157 : H7 shows an increased pathogenicity in mice after the passage through the gastrointestinal tract of the same host

21 January 2018

1 reference

Macropinocytosis in Shiga toxin 1 uptake by human intestinal epithelial cells and transcellular transcytosis

21 January 2018

1 reference

Escherichia coli O157:H7 gastroenteritis and the hemolytic uremic syndrome: an emerging infectious disease

21 January 2018

1 reference

Interaction of Shiga toxin from Escherichia coli with human intestinal epithelial cell lines and explants: Stx2 induces epithelial damage in organ culture

21 January 2018

1 reference

Shiga toxin translocation across intestinal epithelial cells is enhanced by neutrophil transmigration

21 January 2018

1 reference

Human intestinal tissue and cultured colonic cells contain globotriaosylceramide synthase mRNA and the alternate Shiga toxin receptor globotetraosylceramide.

21 January 2018

1 reference

Effect of Shiga toxin 2 on water and ion transport in human colon in vitro

21 January 2018

1 reference

The Shiga toxin 2 B subunit inhibits net fluid absorption in human colon and elicits fluid accumulation in rat colon loops.

21 January 2018

1 reference

Renal and neurological involvement in typical Shiga toxin-associated HUS.

21 January 2018

1 reference

The interactions of human neutrophils with shiga toxins and related plant toxins: danger or safety?

21 January 2018

1 reference

Interactions of Shiga-like toxin with human peripheral blood monocytes

21 January 2018

1 reference

Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction

21 January 2018

1 reference

Verotoxin biology: molecular events in vascular endothelial injury

21 January 2018

1 reference

Shiga toxin 'goes retro' in human primary kidney cells

21 January 2018

1 reference

Human neutrophils and their products induce Shiga toxin production by enterohemorrhagic Escherichia coli

21 January 2018

1 reference

Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome

21 January 2018

1 reference

Impaired neutrophils in children with the typical form of hemolytic uremic syndrome

21 January 2018

1 reference

The oxidative stress induced in vivo by Shiga toxin-2 contributes to the pathogenicity of haemolytic uraemic syndrome

21 January 2018

1 reference

Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome

21 January 2018

1 reference

Involvement of the fractalkine pathway in the pathogenesis of childhood hemolytic uremic syndrome

21 January 2018

1 reference

Chemokine receptor CCR1 disruption limits renal damage in a murine model of hemolytic uremic syndrome

21 January 2018

1 reference

Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome

21 January 2018

1 reference

Shiga toxin-2 results in renal tubular injury but not thrombotic microangiopathy in heterozygous factor H-deficient mice.

21 January 2018

1 reference

Mannan-binding lectin in children with Escherichia coli O157:H7 haemmorrhagic colitis and haemolytic uraemic syndrome.

21 January 2018

1 reference

Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study

21 January 2018

1 reference

Eculizumab in severe Shiga-toxin-associated HUS

21 January 2018

1 reference

Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis

21 January 2018

1 reference

Effects of antibiotics on Shiga toxin 2 production and bacteriophage induction by epidemic Escherichia coli O104:H4 strain

21 January 2018

1 reference

A multivalent peptide library approach identifies a novel Shiga toxin inhibitor that induces aberrant cellular transport of the toxin

21 January 2018

1 reference

Identification of a peptide-based neutralizer that potently inhibits both Shiga toxins 1 and 2 by targeting specific receptor-binding regions

21 January 2018

1 reference

Combinatorial ganglioside biosynthesis

21 January 2018

1 reference

Inhibition of water absorption in human proximal tubular epithelial cells in response to Shiga toxin-2.

21 January 2018

1 reference

Action of shiga toxin type-2 and subtilase cytotoxin on human microvascular endothelial cells

21 January 2018

1 reference

A glucosylceramide synthase inhibitor protects rats against the cytotoxic effects of shiga toxin 2.

21 January 2018

1 reference

ZAK: a MAP3Kinase that transduces Shiga toxin- and ricin-induced proinflammatory cytokine expression.

21 January 2018

1 reference

Shiga toxin 2-induced intestinal pathology in infant rabbits is A-subunit dependent and responsive to the tyrosine kinase and potential ZAK inhibitor imatinib

21 January 2018

1 reference

Manganese blocks intracellular trafficking of Shiga toxin and protects against Shiga toxicosis

21 January 2018

1 reference

ESCHERICHIA COLI CYTOTOXIN, HAEMOLYTIC-URAEMIC SYNDROME, AND HAEMORRHAGIC COLITIS

21 January 2018

1 reference

Improved Inhibitors of Glucosylceramide Synthase

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IUB.1206

0 references

PubMed publication ID

24014500

1 reference